Stock Events

Stock Events

Amylyx Pharmaceuticals (AMLX) Q1 2025 Earnings

4MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-1.75

-1.17

-0.59

-0

Details

Expected EPS

-0.52

Actual EPS

-0.55

Surprise EPS

-0.03

Surprise Percent

+5.77%

Description

Amylyx Pharmaceuticals (AMLX) has reported earnings of -0.55 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.